Circular Economy Enablers
Companies are increasingly embracing sustainability as a strategic response to rising input costs, recognising that responsible practices can lead to long-term resilience in a resource-tight world. In September, Apple announced a new range of smartphones that implement circularity and waste reduction into their design.
The flagship iPhone 15 Pro models will now use structural frames constructed from 100% recycled aluminium, batteries featuring 100% recycled cobalt and 100% recycled rare earth elements in all magnets.
Apple will also use 100% recycled gold in the USB‑C connector and the main logic board will incorporate 100% recycled copper foil. These advancements signify a pivotal shift in global brands acknowledging the imperative of waste mitigation and reducing ecological footprints throughout their supply chains. As consumer purchasing decisions increasingly hinge on these factors, brands that fail to meet expectations risk swift value depreciation in our transition to a sustainable economy. As for our investment solution, the focus remains on identifying the enablers of the circular economy; companies that assist global brands like Apple think about, design and implement greater circularity into their business models. 8
Companion Protect, a pet insurance and animal wellness company based in Kansas City, has successfully secured $USD 27 million in a Series A funding round. This significant investment will play a pivotal role in the company’s mission to revolutionise the pet health sector and make pet healthcare accessible to a broader audience. The funds will be allocated towards developing new products, expanding partnerships and driving digital innovations to enhance the overall customer experience. Noteworthy participants in this funding round include fintech and strategic investors affiliated with CSAA Insurance Group, Avanta Ventures, Liberty Mutual Insurance, shareholder insurance firm Old Republic International Corporation and Stray Dog Enterprises. 9
Medical Cannabis and Life Sciences
According to a recent report by IMARC Group, a leading market research company, the global medical cannabis market was valued at $USD 31.8 billion in 2022 and is expected to reach $57.4 billion by 2028. This translates to a CAGR of 8.47% between 2023-2028. Medical cannabis is used for therapeutic purposes and contains compounds like cannabidiol (CBD) and tetrahydrocannabinol (THC), which interact with the endocannabinoid system in the human body to provide various therapeutic effects. Several factors are driving the growth of the medical cannabis industry. The increasing acceptance of medical cannabis as a treatment option for various medical conditions, backed by scientific research, is a driver. The demand for natural and alternative remedies, especially for chronic pain and neurological disorders, is also contributing to market growth. Favorable regulatory changes, including legalisation for medicinal use in various regions, are creating opportunities for licensed dispensaries and production facilities. Additionally, the expanding applications of medical cannabis, such as treating anxiety, depression and insomnia, are attracting a broader patient base. 10